Pacira Biosciences
PCRX
#6401
Rank
HK$7.70 B
Marketcap
HK$193.41
Share price
2.39%
Change (1 day)
-7.45%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: HK$7.70 Billion

As of September 2026 Pacira Biosciences has a market cap of HK$7.70 Billion. This makes Pacira Biosciences the world's 6401th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$7.70 B-16.81%
2025HK$9.26 B31.58%
2024HK$7.04 B-42.44%
2023HK$12.23 B-11.59%
2022HK$13.84 B-33.77%
2021HK$20.89 B3.7%
2020HK$20.15 B36.31%
2019HK$14.78 B6.47%
2018HK$13.88 B-4.02%
2017HK$14.46 B54.46%
2016HK$9.36 B-57.28%
2015HK$21.93 B-11.78%
2014HK$24.86 B65.79%
2013HK$14.99 B239.44%
2012HK$4.41 B281.65%
2011HK$1.15 B

End of Day market cap according to different sources

On Sep 15th, 2026 the market cap of Pacira Biosciences was reported to be:

HK$7.52 Billion
by Nasdaq info icon info icon
HK$7.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
HK$11.76 B 52.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
HK$0.96 B-87.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
HK$10.07 B 30.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$3.60 B-53.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
HK$0.47 B-93.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$63.62 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA